Literature DB >> 22023663

Fatigue and physical activity levels in patients with liver cirrhosis.

Li-Jan Wu1, Ming-Shun Wu, Gi-Shih Lien, Feng-Chia Chen, Jen-Chen Tsai.   

Abstract

AIMS AND
OBJECTIVES: This study aimed to explore the correlation between fatigue and physical activity in patients with liver cirrhosis.
BACKGROUND: Many patients with liver cirrhosis perceive lower physical functioning and more fatigue than non-cirrhotic individuals. To date, however, few studies have examined the relationship between fatigue and physical activity in this patient population.
DESIGN: This study used a correlation design. Participants were patients with liver cirrhosis recruited from the gastroenterology clinic of a teaching medical centre in Taiwan.
METHODS: Data were collected using a structured questionnaire, consisting of a fatigue scale and a seven-day Physical Activity Recall scale. spss version 13.0 software was used to analyse the data through statistical methods, including one-way analysis of variance, independent t-test and Pearson's correlations.
RESULTS: Patients participating in this study suffered from moderate-to-severe fatigue, and their engagement in physical activity of moderate or higher intensity was decreased. On average, fatigue had a moderate level of influence on physical activity. A significant negative correlation was found between the fatigue level and average seven-day physical activity level.
CONCLUSIONS: Patients with liver cirrhosis can experience severe fatigue, which may reduce their level of physical activity. RELEVANCE TO CLINICAL PRACTICE: Early evaluation of the fatigue level and physical activity constraints in patients with liver cirrhosis should be conducted in the clinic or community. Individualised instructions for patient's physical activity should be provided.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22023663     DOI: 10.1111/j.1365-2702.2011.03900.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  8 in total

Review 1.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

2.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 3.  Cause and management of muscle wasting in chronic liver disease.

Authors:  Srinivasan Dasarathy
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

4.  Nursing Assessment Tool for People With Liver Cirrhosis.

Authors:  Fernanda Raphael Escobar Gimenes; Renata Karina Reis; Patrícia Costa Dos Santos da Silva; Ana Elisa Bauer de Camargo Silva; Elisabeth Atila
Journal:  Gastroenterol Nurs       Date:  2016 Jul-Aug       Impact factor: 0.978

5.  Fatigue and its associated factors in liver transplant recipients in Beijing: a cross-sectional study.

Authors:  Xiao-Hong Lin; Sha Teng; Lu Wang; Jing Zhang; Ya-Bin Shang; Hong-Xia Liu; Yun-Jin Zang
Journal:  BMJ Open       Date:  2017-02-23       Impact factor: 2.692

6.  The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial.

Authors:  Carolina Luana de Mello; Thaís Martins Albanaz da Conceição; Tarcila Dal Pont; Catherine Corrêa Peruzzolo; Mariana Nunes Lúcio; Elaine Paulin
Journal:  Clin Med Insights Gastroenterol       Date:  2018-11-26

7.  Liver cirrhosis turns life into an unpredictable roller coaster: A qualitative interview study.

Authors:  Maria Hjorth; Anncarin Svanberg; Daniel Sjöberg; Fredrik Rorsman; Elenor Kaminsky
Journal:  J Clin Nurs       Date:  2020-10-06       Impact factor: 3.036

Review 8.  Exercise as an intervention for patients with end-stage liver disease: Systematic review.

Authors:  Cameron T Locklear; Pegah Golabi; Lynn Gerber; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.